Stockpiling of pain relief and cough/cold OTCs globally at the beginning of the coronavirus pandemic helped lift Sanofi’s Consumer Healthcare sales by 4.2% at constant exchange rates to €1.3bn ($1.4bn) in the first quarter of 2020.
Sanofi Benefits From Stockpiling In Q1, Predicts Long-Term Uplift In Supplements Demand
Sanofi benefits from coronavirus-triggered stockpiling in Q1, with Consumer Healthcare head Alan Main suggesting the pandemic may have turned more consumers into regular dietary supplement users
More from Earnings
Direct seller's going to need more than larger number of distributors to generate sustainable growth, analysts say.
Firm’s future, as a separate business nearly 90% owned by Bausch Health, or as a standalone with different ownership or one not controlled by a majority owner, claims high profile in analysts’ comments and predictions. B+L is in the driver’s seat, they say.
Haleon highlighted consistent market share gains in China as it reported third-quarter results.
A better than expected showing from its Health business in its latest quarter has teed up Reckitt for a big finish to the year.
More from Business
Round-up of the latest people moves: CHP Australia names new chief exec; Opella appoints Vietnam head; Ascendis makes permanent CFO appointment.
Fitcrunch brand and CEO move to 1440 Foods; BBB National Programs expands leadership; Fighting Weight names CEO at launch; OmegaXL Sport connects with Model Elizabeth Gutiérrez; Board member moves to Natural Grocer helm; Quest Nutrition provides protein snacks for USA Rugby; Lionel Messi’s hydration beverage distribution spreads.
GuruNanda appealing a National Advertising Division decision, following a review of a Procter & Gamble challenge, that it cease using a “natural teeth whitening” claim for its namesake brand pulling oil, mouthwash and gel pen.